TrialCancer research and treatment2024
A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia Patients.
Ja Min Byun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.